Alamar Biosciences, Inc. SEC filings ALMR

Alamar Biosciences, Inc. has 63 filings in SEC EDGAR's recent list, going back to Jan 9, 2026. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations, officer or director change). The company's fiscal year ends on December 31.

Alamar Biosciences, Inc. SEC filings
Form Description Filed Period
4 Insider transaction Nov 5, 2026 Nov 3, 2026
10-Q Quarterly report Nov 4, 2026 Sep 30, 2026
4 Insider transaction Nov 3, 2026 Oct 30, 2026
8-K Current report
Results of operations, Officer or director change
Nov 3, 2026 Oct 30, 2026
4 Insider transaction Oct 29, 2026 Oct 27, 2026
4 Insider transaction Oct 27, 2026 Oct 23, 2026
4 Insider transaction Oct 23, 2026 Oct 21, 2026
4 Insider transaction Oct 21, 2026 Oct 19, 2026
4 Insider transaction Oct 19, 2026 Oct 15, 2026
144 Notice of proposed sale Oct 14, 2026 —
144 Notice of proposed sale Oct 14, 2026 —
144 Notice of proposed sale Oct 14, 2026 —
144 Notice of proposed sale Oct 14, 2026 —
4 Insider transaction Sep 16, 2026 Sep 14, 2026
3 Initial insider ownership Sep 16, 2026 Sep 14, 2026
4 Insider transaction Sep 3, 2026 Sep 1, 2026
3 Initial insider ownership Sep 3, 2026 Sep 1, 2026
8-K Current report
Officer or director change
Sep 1, 2026 Aug 28, 2026
SCHEDULE 13G Ownership over 5% (passive) Aug 13, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Aug 11, 2026 —
10-Q Quarterly report Aug 11, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 10, 2026 Aug 10, 2026
8-K Current report
Other events
Jul 15, 2026 Jul 15, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Jul 7, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Jul 2, 2026 —
10-Q Quarterly report May 8, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 8, 2026 May 8, 2026
SCHEDULE 13D Ownership over 5% (active) Apr 23, 2026 —
SCHEDULE 13D Ownership over 5% (active) Apr 23, 2026 —
4 Insider transaction Apr 22, 2026 Apr 20, 2026
EFFECT Filing Apr 20, 2026 —
4 Insider transaction Apr 20, 2026 Apr 16, 2026
4 Insider transaction Apr 20, 2026 Apr 20, 2026
4 Insider transaction Apr 20, 2026 Apr 20, 2026
4 Insider transaction Apr 20, 2026 Apr 16, 2026
4 Insider transaction Apr 20, 2026 Apr 16, 2026
4 Insider transaction Apr 20, 2026 Apr 16, 2026
4 Insider transaction Apr 20, 2026 Apr 16, 2026
4 Insider transaction Apr 20, 2026 Apr 16, 2026
S-8 Employee stock plan registration Apr 20, 2026 —
8-K Current report
Bylaw or fiscal year change, Other events
Apr 20, 2026 Apr 20, 2026
POS AM Filing Apr 20, 2026 —
424B4 Prospectus Apr 17, 2026 —
EFFECT Filing Apr 16, 2026 —
3 Initial insider ownership Apr 16, 2026 Apr 16, 2026
3 Initial insider ownership Apr 16, 2026 Apr 16, 2026
3 Initial insider ownership Apr 16, 2026 Apr 16, 2026
3 Initial insider ownership Apr 16, 2026 Apr 16, 2026
3 Initial insider ownership Apr 16, 2026 Apr 16, 2026
3 Initial insider ownership Apr 16, 2026 Apr 16, 2026
3 Initial insider ownership Apr 16, 2026 Apr 16, 2026
3 Initial insider ownership Apr 16, 2026 Apr 16, 2026
3 Initial insider ownership Apr 16, 2026 Apr 16, 2026
3 Initial insider ownership Apr 16, 2026 Apr 16, 2026
S-1MEF Filing Apr 16, 2026 —
CERT Filing Apr 16, 2026 —
S-1/A Amended registration statement Apr 16, 2026 —
8-A12B Filing Apr 15, 2026 —
S-1/A Amended registration statement Apr 13, 2026 —
S-1 Registration statement Mar 27, 2026 —
DRS/A Filing Mar 12, 2026 —
DRS/A Filing Feb 17, 2026 —
DRS Filing Jan 9, 2026 —

Showing 63 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Laboratory Analytical Instruments (SIC 3826)
Listed as
ALMR (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Fremont, CA
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
2104204

Other Laboratory Analytical Instruments companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.